Trial · NCT03428360
Results by group27
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 27
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Subjects in the Safety Analysis Set With at Least 1 Treatment-emergent Adverse Event (TEAE) | Safety Analysis Set: Enrolled Subjects With Epilepsy Who Received at Least 1 Dose of Study Drug | At least 1 TEAE | 84 | Participants | |
| Number of Subjects in the Safety Analysis Set With at Least 1 Treatment-emergent Adverse Event (TEAE) | Safety Analysis Set: Enrolled Subjects With Epilepsy Who Received at Least 1 Dose of Study Drug | At least 1 severe TEAE | 14 | Participants | |
| Number of Subjects in the Safety Analysis Set With at Least 1 Treatment-emergent Adverse Event (TEAE) | Safety Analysis Set: Enrolled Subjects With Epilepsy Who Received at Least 1 Dose of Study Drug | At least 1 study drug related TEAE | 10 | Participants | |
| Number of Subjects in the Safety Analysis Set With at Least 1 Treatment-emergent Adverse Event (TEAE) | Safety Analysis Set: Enrolled Subjects With Epilepsy Who Received at Least 1 Dose of Study Drug | At least 1 severe and related TEAE | 1 | Participants | |
| Number of Subjects in the Safety Analysis Set With at Least 1 Treatment-emergent Adverse Event (TEAE) | Safety Analysis Set: Enrolled Subjects With Epilepsy Who Received at Least 1 Dose of Study Drug | At least 1 serious TEAE | 18 | Participants | |
| Number of Subjects in the Safety Analysis Set With at Least 1 Treatment-emergent Adverse Event (TEAE) | Safety Analysis Set: Enrolled Subjects With Epilepsy Who Received at Least 1 Dose of Study Drug | At least 1 serious and related TEAE | 1 | Participants | |
| Number of Subjects in Safety Analysis Set With Adverse Events of Special Interest (AESI) | Subjects With Epilepsy | Any adverse event of special interest | 32 | participants | |
| Number of Subjects in Safety Analysis Set With Adverse Events of Special Interest (AESI) | Subjects With Epilepsy | Any oral irritation adverse event | 3 | participants | |
| Number of Subjects in Safety Analysis Set With Adverse Events of Special Interest (AESI) | Subjects With Epilepsy | Any oral safety adverse event | 8 | participants | |
| Number of Subjects in Safety Analysis Set With Adverse Events of Special Interest (AESI) | Subjects With Epilepsy | Any potential abuse related adverse event | 21 | participants | |
| Number of Subjects in Safety Analysis Set With Adverse Events of Special Interest (AESI) | Subjects With Epilepsy | Any abuse related adverse event | 1 | participants | |
| Number of Subjects in Safety Analysis Set With Adverse Events of Special Interest (AESI) | Subjects With Epilepsy | Any other adverse event of special interest | 8 | participants | |
| Usability Assessment: Number of Use Occasions Where Difficulty in Opening the Outer Packaging Was Recorded. | Total Use Occasions | 211 | total number of use occasions | ||
| Usability Assessment: Ability to Open Foil Pouch on Each Use Occasion | Study Drug Use Occasions | Yes, I had difficulty opening the foil pouch | 391 | total number of use occasions | |
| Usability Assessment: Ability to Open Foil Pouch on Each Use Occasion | Study Drug Use Occasions | No, I did not have difficulty opening the foil pouch | 957 | total number of use occasions | |
| Usability Assessment: Ability to Remove Study Drug From Foil Pouch on Each Use Occasion | Study Drug Use Occasions | Yes, I had difficulty removing study drug from pouch on this occasion | 47 | total number of use occasions rpoeted | |
| Usability Assessment: Ability to Remove Study Drug From Foil Pouch on Each Use Occasion | Study Drug Use Occasions | No, I did not have difficulty removing study drug from the pouch on this occasion | 1301 | total number of use occasions rpoeted | |
| Number of Occasions With Successful Insertion/Retention in Cheek | Study Drug Use Occasions | 1330 | Number of events | ||
| Usability Assessment: Difficulty Inserting DBF Against the Buccal Mucosa (Number of Attempts to Insert Film for Each Use Occasion) | Study Drug Use Occasions | Number of occasions where it required 1 attempt to insert film | 1268 | Number of events | |
| Usability Assessment: Difficulty Inserting DBF Against the Buccal Mucosa (Number of Attempts to Insert Film for Each Use Occasion) | Study Drug Use Occasions | Number of occasions that required 2 attempts to insert film | 38 | Number of events |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03428360/results